Your browser doesn't support javascript.
loading
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
Wang, Anxin; Meng, Xia; Tian, Xue; Johnston, S Claiborne; Li, Hao; Bath, Philip M; Zuo, Yingting; Xie, Xuewei; Jing, Jing; Lin, Jinxi; Wang, Yilong; Zhao, Xingquan; Li, Zixiao; Jiang, Yong; Liu, Liping; Wang, Feng; Li, Ying; Liu, Jingyao; Wang, Yongjun.
Afiliação
  • Wang A; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Meng X; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Tian X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Johnston SC; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Li H; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Bath PM; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zuo Y; Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
  • Xie X; Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
  • Jing J; Dell Medical School, University of Texas at Austin, Austin, TX, USA.
  • Lin J; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wang Y; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zhao X; Stroke Trials Unit, Mental Health and Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Li Z; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Jiang Y; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Liu L; Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
  • Wang F; Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
  • Li Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Liu J; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Ann Neurol ; 91(3): 380-388, 2022 03.
Article em En | MEDLINE | ID: mdl-34951042
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Ataque Isquêmico Transitório / Aspirina / Citocromo P-450 CYP2C19 / Clopidogrel / AVC Isquêmico / Hemorragia Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Ataque Isquêmico Transitório / Aspirina / Citocromo P-450 CYP2C19 / Clopidogrel / AVC Isquêmico / Hemorragia Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China